Latest News
Merck and Moderna mRNA Cancer Vaccine Prevents Recurrence
Merck & Co. and Moderna Inc. announced that their personalized mRNA cancer vaccine intismeran prevented melanoma recurrence in a final-stage trial.
Bringing you stories that vibe with your fashion